insights_auto
Why is ORX up 11.90%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 1.01
arrow_upward
+11.90%(+0.11) 1D
Nov 18, 5:29:44 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.91
High
SEKÂ 1.07
Low
SEKÂ 0.88
Mkt. cap
352.99M
Avg. vol.
734.04K
Volume
1.47M
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.91
High
SEKÂ 1.07
Low
SEKÂ 0.88
Mkt. cap
352.99M
Avg. vol.
734.04K
Volume
1.47M
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
34 minutes ago
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%
Barron's
·
1 hour ago
Discount Retailer Stock Tops S&P 500 on Strong Holiday Outlook
ChartMill
·
1 hour ago
S&P 500 Unusual Volume Movers: Nov. 18, 2026
Traders Union
·
20 minutes ago
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com